Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy

Pediatric Blood and Cancer

Volumn 48, Issue 4, 2007, Pages 435-440

  Cruz, Luciane B ^a,b   Ribeiro, Anelise S ^a   Rech, Angela ^a   Rosa, Lauro G N ^a   Castro Jr , Cláudio G ^a   Brunetto, Algemir L ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Cancer; Chemotherapy; Children; Laser; Mucositis

Indexed keywords

CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE; IRINOTECAN; METHOTREXATE;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENTAL CARE; DISEASE SEVERITY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; LOW LEVEL LASER THERAPY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MOUTH HYGIENE; MUCOSA INFLAMMATION; ORAL MUCOSAL DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ETOPOSIDE; FEMALE; HUMANS; IFOSFAMIDE; LASER THERAPY, LOW-LEVEL; MALE; METHOTREXATE; MOUTH MUCOSA; NEOPLASMS; NUTRITIONAL STATUS; ORAL HYGIENE; SEVERITY OF ILLNESS INDEX; STOMATITIS; TREATMENT OUTCOME;

EID: 33847350659     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20943     Document Type: Article

References (27)

1. Kenny SA. Effect of two oral care protocols on the incidence of stomatitis in hematology patients. Cancer Nurs 1990;13:345-353.
2. Chan CWH, Chang AM, Molassiotis A, et al. Oral complications in Chinese cancer patients undergoing chemotherapy. Support Care Cancer 2003;11:48-55.
3. Cheng KKF, Molassiotis A, Chang AM, et al. Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients. Eur J Cancer 2001;37:2056-2063.
4. Duncam M, Grant G. Review article: Oral and intestinal mucositis-causes and possible treatments. Aliment Pharmacol Ther 2003;18:853-874.
5. Balis FM, Holcenberg JS, Blaney SM. General principles of chemotherapy. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 4th ed. Philadelphia, PA: Lippincott Williams E Wilkins, 2002, 264p.
6. Picco JL, Ávila-Garavito A, Naccache P. Mucositis: Its occurrence, consequences and treatment in the oncology setting. Oncologist 1998;3:446-451.
7. Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: Unanswered questions. Oral Oncol 2003;3:91-100.
8. Bensadoun RJ, Franquin JC, Cias G, et al. Low-energy He/Ne laser in the prevention of radiation-induced mucositis. A multicenter phase III randomized study in patients with head and neck cancer. Support Care Center 1999;7:217-218.
9. Karu TI. Photobiological fundamentals of low-power laser therapy. J Quantum Electronics 1987;23:1703-1717.
10. Cowen D, Tardieu C, Schubert M, et al. Low energy Helium-Neon laser in prevention of oral mucositis in patients undergoing bone marrow transplant: Results of a double blind randomized trial. Int J Radiat Oncol Biol Phys 1997;38:697-703.
11. Barasch A, Peterson DE, Tanzer JM, et al. Helium-neon effects on conditioning-induced oral mucositis in bone marrow transplantation patients. Cancer 1995;76:2550-2556.
12. Whelan HT, Connelly JF, Hodgson BD, et al. NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients. J Clin Laser Med Surg 2002;20:319-324.
13. Gordón-Nuñez MA, Oliveira PT, Pinto LP. Oral mucositis and status of oral health in pediatric patients with cancer. Rev Bras Patol Oral 2002;1:5-12.
14. Opperman RV, Rosing CK. Prevenção e tratamento das doenças periodontais. Promoção de Saúde Bucal-ABOPREV. São Paulo: Artes Médicas, 1999, pp 261-266.
15. Available on world wide web: http://www.uniodontomao.com.br/ dicas/dir_dicas/dica06.htm [update 2002 dez 07].
16. World Health Organization. Physical status: The use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854:1-452.
17. National Cancer Institute (NCI), National Institute Health (NIH), Common Toxicity Criteria (CTC). Version 2.0, March 1998.
18. SPSS Program for Windows. Rel. 12.0.0. Chicago: SPSS Inc., 2003.
19. Rubenstein EB, Peterson DE, Schubert M, et al. Clinical practice guidelines for the prevention and treatment of cancer-induced oral and gastrointestinal mucositis. Cancer Supplement 2004;100:2026-2046.
20. Sonis ST. Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 1998;34:39-43.
21. Araújo MT, Araújo RP, Campos EJ. Estudo in vivo e ex vivo da atividade bactericida da clorexidina 0.12% e a 0.2% e dos produtos farmacológicos Listerine e Duplak. Rev Odonto Cienc 2001;16:187-197.
22. Pitten FA, Kiefer T, Buth C, et al. Do cancer patients with chemotherapy-induced leukopenia benefit from an antiseptic chlorhexidine based oral rinse? A double-blind, block-randomized, controlled study. J Hospit Infect 2003;53:283-291.
23. Bonnaure-Mallet M, Bunetel L, Tricot-Doleux S, et al. Oral complication during treatment of malignant diseases in childhood: Effects of tooth brushing. Eur J Cancer 1998;34:1588-1591.
24. Plevová P. Prevention and treatment of chemotherapy-and radiotherapy-induced mucositis: A review. Oral Oncol 1999;35:453-470.
25. Raber-Durlacher JE, Weijl NI, Abu Saris M, et al. Oral mucositis in patients treated with chemotherapy for solid tumors: A retrospective analysis of 150 cases. Support Care Cancer 2000;8:366-371.
26. Huang Ey, Leung SW, Wang CJ, et al. Oral glutamine to alleviate radiation-induced oral mucositis: A pilot randomized trial. Int J Radiation Oncology 2000;46:535-539.
27. Walsh LJ. The current status of low level therapy in dentistry. Part 1. Soft tissue applications. Australian Dental J 1997;42:247-254.